Herpes zoster subunit vaccine for the prevention of herpes zoster.

CONCLUSION: HZ/su vaccine is a recently approved, preferred option to reduce the risks of HZ and PHN in adults 50 years of age or older. Pain at the injection site is the most common AE associated with use of the vaccine. PMID: 29880523 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29880523?dopt=Abstract

Source: American Journal of Health-System Pharmacy : AJHP - June 10, 2018 Category: Drugs & Pharmacology Authors: Symoniak MR, Farrokh P, Gandhi MA, Slish JC Tags: Am J Health Syst Pharm Source Type: research